MBB Public Markets I LLC Buys Shares of 3,920 The Cooper Companies, Inc. $COO

Key Points

• MBB Public Markets I LLC has initiated a position in The Cooper Companies, purchasing 3,920 shares valued at approximately $331,000 in the first quarter.
• Several research firms have reduced their price targets for Cooper Companies, with Robert W. Baird cutting their target from $97.00 to $85.00, reflecting a shift in analyst ratings for the stock.
• Insiders from Cooper Companies have been active in buying stock; EVP Brian G. Andrews acquired 1,525 shares worth $100,162, indicating confidence in the company's future.

MBB Public Markets I LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,920 shares of the medical device company's stock, valued at approximately $331,000.

A number of other institutional investors and hedge funds have also modified their holdings of COO. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies during the 1st quarter worth about $33,000. City Holding Co. purchased a new stake in Cooper Companies during the 1st quarter worth approximately $34,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies during the first quarter valued at approximately $40,000. Larson Financial Group LLC lifted its position in shares of Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after acquiring an additional 664 shares in the last quarter. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after acquiring an additional 532 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insiders Place Their Bets

In related news, COO Gerard H. Warner III acquired 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer owned 18,319 shares in the company, valued at approximately $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Albert G. White III bought 10,000 shares of the firm's stock in a transaction on Friday, September 5th. The stock was bought at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company's stock, valued at $15,466,466.89. The trade was a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 15,975 shares of company stock worth $1,079,566 over the last ninety days. Company insiders own 1.98% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Loop Capital set a $100.00 price target on Cooper Companies in a research report on Tuesday, June 17th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a report on Thursday, August 28th. Morgan Stanley set a $76.00 target price on shares of Cooper Companies and gave the company an "equal weight" rating in a research report on Thursday, August 28th. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $86.64.

Cooper Companies Trading Down 0.9%

COO stock traded down $0.59 during trading on Wednesday, reaching $67.66. 2,397,249 shares of the stock were exchanged, compared to its average volume of 3,158,719. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $13.45 billion, a price-to-earnings ratio of 33.33, a P/E/G ratio of 1.73 and a beta of 0.97. The business has a 50 day moving average price of $71.75 and a 200-day moving average price of $76.31. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the firm earned $0.96 EPS. The business's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.